نتایج جستجو برای: rhepo

تعداد نتایج: 239  

2011
Reza Ahangari Cohan Armin Madadkar-Sobhani Hossein Khanahmad Farzin Roohvand Mohammad Reza Aghasadeghi Mohammad Hossein Hedayati Zahra Barghi Mehdi Shafiee Ardestani Davoud Nouri Inanlou Dariush Norouzian

BACKGROUND Recombinant human erythropoietin (rhEPO) is considered to be one of the most pivotal pharmaceutical drugs in the market because of its clinical application in the treatment of anemia-associated disorders worldwide. However, like other therapeutic proteins, it does not have suitable pharmacokinetic properties for it to be administrated at least two to three times per week. Chemoselect...

2012
Pengjie Wu Ning Zhang Xi Wang Chi Zhang Teng Li Xianghui Ning Kan Gong

Co-expression of erythropoietin (Epo) and erythropoietin receptor (EpoR) has been found in various non-hematopoietic cancers including hereditary and sporadic renal cell carcinomas (RCC), but the Epo/EpoR autocrine and paracrine mechanisms in tumor progression have not yet been identified. In this study, we used RNA interference method to down-regulate EpoR to investigate the function of Epo/Ep...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
R Stasi M Brunetti E Terzoli E Abruzzese S Amadori

BACKGROUND Once-weekly dosing of recombinant human erythropoietin (rhEPO) in patients with myelodysplastic syndromes (MDS) has not been investigated thoroughly. We performed a clinical trial to evaluate the effects of this new dosing regimen in patients with MDS who were unresponsive to the conventional three-times-weekly schedule. PATIENTS AND METHODS Forty-eight patients with low- or interm...

Journal: :Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2013
Wolfgang Jelkmann

Human erythropoietin (Epo) is a 30.4 kDa glycoprotein hormone composed of a single 165 amino acid residues chain to which four glycans are attached. The kidneys are the primary sources of Epo, its synthesis is controlled by hypoxia-inducible transcription factors (HIFs). Epo is an essential factor for the viability and proliferation of erythrocytic progenitors. Whether Epo exerts cytoprotection...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005
Yukika Kitamura Kazunori Satoh Takashi Satoh Manabu Takita Akihiro Matsuura

BACKGROUND l-Carnitine can alleviate uraemic anaemia in haemodialysis patients by improving erythrocyte membrane functions or erythropoiesis, which are depressed under uraemic conditions. l-Carnitine and palmitoyl-l-carnitine were reported to increase the formation of colony-forming unit-erythroid (CFU-E) colonies in cultures of fetal mouse liver cells, an effect that depended on the concentrat...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2009
Pascal E Sanchez Raafat P Fares Jean-Jacques Risso Chantal Bonnet Sandrine Bouvard Marion Le-Cavorsin Béatrice Georges Colette Moulin Amor Belmeguenai Jacques Bodennec Anne Morales Jean-Marc Pequignot Etienne-Emile Baulieu Robert A Levine Laurent Bezin

Erythropoietin receptor (EpoR) binding mediates neuroprotection by endogenous Epo or by exogenous recombinant human (rh)Epo. The level of EpoR gene expression may determine tissue responsiveness to Epo. Thus, harnessing the neuroprotective power of Epo requires an understanding of the Epo-EpoR system and its regulation. We tested the hypothesis that neuronal expression of EpoR is required to ac...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید